| Title |
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
|
|---|---|
| Published in |
Frontiers in Pharmacology, August 2020
|
| DOI | 10.3389/fphar.2020.01124 |
| Pubmed ID | |
| Authors |
Pasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D’Angelo, Francesco Donati, Maddalena Giannella, Sara Tedeschi, Renato Pascale, Michele Bartoletti, Giulia Tesini, Mauro Biffi, Benilde Cosmi, Carmine Pizzi, Pierluigi Viale, Nazzareno Galié |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | 14% |
| India | 1 | 14% |
| Comoros | 1 | 14% |
| Italy | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 57% |
| Scientists | 2 | 29% |
| Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 108 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 15 | 14% |
| Student > Master | 13 | 12% |
| Other | 10 | 9% |
| Researcher | 8 | 7% |
| Student > Postgraduate | 7 | 6% |
| Other | 20 | 19% |
| Unknown | 35 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 36% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 8% |
| Nursing and Health Professions | 6 | 6% |
| Engineering | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Other | 10 | 9% |
| Unknown | 39 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2021.
All research outputs
#6,738,978
of 24,046,191 outputs
Outputs from Frontiers in Pharmacology
#2,875
of 17,889 outputs
Outputs of similar age
#141,355
of 402,081 outputs
Outputs of similar age from Frontiers in Pharmacology
#93
of 439 outputs
Altmetric has tracked 24,046,191 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 17,889 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 402,081 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 439 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.